FDA broadens APDS treatment options

• by Kathryn Wighton

• September 14, 2026

Risk of Injury Among Children and Youths Whose Mothers Experienced Violent Injury: A Systematic Review and

• by Marissa Fazio, Barbara Haas, Sarah Bahreinian, Sorina Andrei, Hilary K. Brown, Tharani Raveendran, Natasha Saunders

• September 11, 2026

Error in Figure

• September 14, 2026

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

• by Kathryn Wighton

• September 4, 2026

• 2 min